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Erratum 
Rothman, R.B., A. Mele, A.A. Reid, H. Akunne, N. Greig, A. Thurkauf, K.C. Rice and A. Pert, Tight binding 
dopamine reuptake inhibitors as cocaine antagonists: A strategy for drug development (1989) FEBS Letters 257, 
341-344. 
An unedited draft of the manuscript was inadvertently published. The publisher would like to make the following cor- 
rections: 
The first sentence of the second column 
on page 341 should read: 
Interestingly, mazindol nomifensine and bupropion are 
self-administered by animals [ 1 l- 141 
The second sentence of the last paragraph 
on page 343 should read: 
The recent report that mazindol attenuates cocaine 
craving and euphoria even after one day of administra- 
tion 1251, suggests that mazindol may, like GBR12909, 
be acting to attenuate the effects of cocaine. However, 
although administration of antidepressants uch as 
desipramine to humans helps attenuate the craving for 
cocaine [26,27], this effect takes several weeks to 
develop, and does not appear related to a direct an- 
tagonism of cocaine. 
152 
instead of 
Interestingly, whereas mazindol and nomifensine are 
self-administered by animals [ 1 l- 131, bupropion is not 
v41. 
instead ojI- 
Although administration of anti-depressants uch as 
desipramine and mazindol [25-271 to humans helps at- 
tenuate the craving for cocaine, this effect takes several 
weeks to develop, and does not appear related to a 
direct antagonism of the cocaine. 
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